SCHEMBL7371014

SCHEMBL7371014

Cc1ccc(S(=O)(=O)S)cc1Cc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
CA4 P22748 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
AR P10275 4/20 0.47
FFAR1 O14842 3/20 0.46
TRIM24 O15164 1/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PIR O00625 1/20 0.44
MGLL Q99685 3/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605218 0.87 POLB (0.41) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL6952271 0.86 CA12 (0.48) CA12CA1CA2CA9CA4
SCHEMBL21218518 0.80 MAOB (0.47) RAB9ASMN1; SMN2
SCHEMBL21218509 0.78 LMNA (0.55) RAB9ASMN1; SMN2
SCHEMBL1009096 0.78 MAOB (0.51) RAB9A
Bromide SCHEMBL23040899 0.77 MAOB (0.44) NPC1RAB9ASMN1; SMN2
SCHEMBL6603744 0.76 IDH1 (0.43)
SCHEMBL6605334 0.76 CA12 (0.43) CA12CA1CA2CA9CA7
SCHEMBL30040870 0.75 MAOB (0.43) NPC1RAB9ASMN1; SMN2
SCHEMBL23040900 0.75 MAOB (0.43) NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed